The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated in children, ...

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic ...

Last week, the U.S. Department of Justice announced that GlaxoSmithKline had agreed to pay $3 billion in criminal and civil fines for its misdeeds in inappropriately marketing Paxil and another ...

Photo by Flickr user Ian Wilson Doctors will no longer be paid to speak on behalf of GlaxoSmithKline and its products, the British drug maker said Tuesday. In addition, the pharmaceutical company ...

GlaxoSmithKline's consumer health outfit draws buyout interest: report. But a 10% premarket dip for Unilever stock in New York Tuesday suggests investors aren’t buying the conglomerate’s argument.

Following Pfizer and AbbVie, GlaxoSmithKline is the latest drug major to launch a trade secrets case against an ex-staffer. For GSK, the case comes after several other high-profile trade secrets ...

GlaxoSmithKline Price Perofrmance. Spin-Off Research. GSK reaffirmed its FY22 guidance and expects revenues to grow 5-7% at CER. The Speciality Medicine segment is expected to grow by ~10% at CER ...

Review the current GlaxoSmithKline Pharmaceuticals Ltd (GLAXO:XNSE) dividend yield and history to decide if GLAXO is the best investment for you.